Literature DB >> 2568343

Contribution of autolysin to virulence of Streptococcus pneumoniae.

A M Berry1, R A Lock, D Hansman, J C Paton.   

Abstract

Insertion-duplication mutagenesis was used to construct an autolysin-negative derivative of Streptococcus pneumoniae. This derivative was obtained by first transforming the nonencapsulated strain Rx1 with a derivative of the vector pVA891 carrying a 375-base-pair TaqI DNA fragment from the middle of the autolysin structural gene. DNA was extracted from the resultant erythromycin-resistant, autolysin-negative rough pneumococcus and used to transform S. pneumoniae D39, a virulent type 2 strain. Several erythromycin-resistant transformants were obtained from two independent experiments, and none of these transformants produced autolysin. Southern blot analysis confirmed that the autolysin gene in these transformants had been interrupted by the plasmid-derived sequences. The autolysin-negative mutants showed markedly reduced virulence for mice compared with that of strain D39; intranasal and intraperitoneal 50% lethal doses were increased 10(2)- and 10(5)-fold, respectively. Autolysin production was reinstated in one of the mutants by back-transformation with the cloned autolysin gene, with the concomitant loss of erythromycin resistance; the virulence of this isolate for mice was indistinguishable from that of D39. The importance of autolysin in pathogenesis was confirmed by immunization-challenge studies. Mice immunized with purified autolysin survived significantly longer than did control mice after intranasal challenge with strain D39. This study provides direct evidence that the pneumococcal autolysin contributes to virulence and identifies it as a potential vaccine antigen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568343      PMCID: PMC313450          DOI: 10.1128/iai.57.8.2324-2330.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Purification of the pneumococcal N-acetylmuramyl-L-alanine amidase to biochemical homogeneity.

Authors:  J V Höltje; A Tomasz
Journal:  J Biol Chem       Date:  1976-07-25       Impact factor: 5.157

2.  Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.

Authors:  A M Berry; J Yother; D E Briles; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

3.  Transformation of encapsulated Streptococcus pneumoniae.

Authors:  J Yother; L S McDaniel; D E Briles
Journal:  J Bacteriol       Date:  1986-12       Impact factor: 3.490

4.  Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae.

Authors:  R A Lock; J C Paton; D Hansman
Journal:  Microb Pathog       Date:  1988-12       Impact factor: 3.738

5.  Insertional inactivation of the major autolysin gene of Streptococcus pneumoniae.

Authors:  A Tomasz; P Moreillon; G Pozzi
Journal:  J Bacteriol       Date:  1988-12       Impact factor: 3.490

6.  Destruction of low efficiency markers is a slow process occurring at a heteroduplex stage of transformation.

Authors:  N B Shoemaker; W R Guild
Journal:  Mol Gen Genet       Date:  1974

7.  Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin.

Authors:  M Nandoskar; A Ferrante; E J Bates; N Hurst; J C Paton
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

8.  Overproduction and rapid purification of the amidase of Streptococcus pneumoniae.

Authors:  J L García; E García; R López
Journal:  Arch Microbiol       Date:  1987       Impact factor: 2.552

9.  Purification and immunological characterization of neuraminidase produced by Streptococcus pneumoniae.

Authors:  R A Lock; J C Paton; D Hansman
Journal:  Microb Pathog       Date:  1988-01       Impact factor: 3.738

10.  Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).

Authors:  L S McDaniel; J Yother; M Vijayakumar; L McGarry; W R Guild; D E Briles
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  111 in total

1.  The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin.

Authors:  P Balachandran; S K Hollingshead; J C Paton; D E Briles
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

2.  The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses.

Authors:  K Overweg; A Kerr; M Sluijter; M H Jackson; T J Mitchell; A P de Jong; R de Groot; P W Hermans
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  RegR, a global LacI/GalR family regulator, modulates virulence and competence in Streptococcus pneumoniae.

Authors:  Sabine Chapuy-Regaud; A David Ogunniyi; Nicole Diallo; Yvette Huet; Jean-François Desnottes; James C Paton; Sonia Escaich; Marie-Claude Trombe
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Analysis of a peptidoglycan hydrolase gene from Staphylococcus aureus NCTC 8325.

Authors:  X Wang; N Mani; P A Pattee; B J Wilkinson; R K Jayaswal
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

5.  Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant.

Authors:  Richard Malley; Sarah C Morse; Luciana C C Leite; Ana Paula Mattos Areas; Paulo Lee Ho; Flavia S Kubrusly; Igor C Almeida; Porter Anderson
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

6.  Protein serine/threonine kinase StkP positively controls virulence and competence in Streptococcus pneumoniae.

Authors:  Jose Echenique; Aras Kadioglu; Susana Romao; Peter W Andrew; Marie-Claude Trombe
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

7.  Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo.

Authors:  Laura R Marks; G Iyer Parameswaran; Anders P Hakansson
Journal:  Infect Immun       Date:  2012-05-29       Impact factor: 3.441

8.  Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.

Authors:  R Malley; M Lipsitch; A Stack; R Saladino; G Fleisher; S Pelton; C Thompson; D Briles; P Anderson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

9.  Large-scale identification of virulence genes from Streptococcus pneumoniae.

Authors:  A Polissi; A Pontiggia; G Feger; M Altieri; H Mottl; L Ferrari; D Simon
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 10.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.